Oppenheimer (OPY) Stock Forecast, Price & News

Oppenheimer's stock was trading at $42.33 at the start of the year. Since then, OPY stock has decreased by 7.4% and is now trading at $39.19.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Friday, August 4th 2023.
View our OPY earnings forecast.

Oppenheimer Holdings Inc. (NYSE:OPY) issued its quarterly earnings results on Thursday, July, 30th. The financial services provider reported $1.34 EPS for the quarter. The financial services provider had revenue of $264.73 million for the quarter. Oppenheimer had a net margin of 3.16% and a trailing twelve-month return on equity of 4.68%.

Oppenheimer announced a quarterly dividend on Friday, April 28th. Shareholders of record on Friday, May 12th will be paid a dividend of $0.15 per share on Friday, May 26th. This represents a $0.60 annualized dividend and a dividend yield of 1.53%. The ex-dividend date is Thursday, May 11th.
Read our dividend analysis for OPY.

ETFs with the largest weight of Oppenheimer (NYSE:OPY) stock in their portfolio include AdvisorShares Dorsey Wright Micro-Cap ETF (DWMC), Hartford Multifactor Small Cap ETF (ROSC).Vanguard U.S. Quality Factor ETF (VFQY),

Oppenheimer (NYSE:OPY) pays an annual dividend of $0.60 per share and currently has a dividend yield of 1.62%. The dividend payout ratio is 19.11%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for OPY.

113 employees have rated Oppenheimer Chief Executive Officer Albert G. Lowenthal on Glassdoor.com. Albert G. Lowenthal has an approval rating of 43% among the company's employees. This puts Albert G. Lowenthal in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Oppenheimer investors own include AbbVie (ABBV), International Business Machines (IBM), Pfizer (PFE), Verizon Communications (VZ), Waddell & Reed Financial (WDR), Exxon Mobil (XOM), Boeing (BA), ChemoCentryx (CCXI), Salesforce (CRM) and Editas Medicine (EDIT).

Oppenheimer trades on the New York Stock Exchange (NYSE) under the ticker symbol "OPY."

Oppenheimer's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (5.44%), Dimensional Fund Advisors LP (4.80%), State Street Corp (1.45%), AQR Capital Management LLC (1.44%), Geode Capital Management LLC (1.30%) and Bank of New York Mellon Corp (0.63%). Insiders that own company stock include A Winn Oughtred, Dennis P Mcnamara and Jeffrey J Alfano.
View institutional ownership trends.

Shares of OPY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of OPY stock can currently be purchased for approximately $39.19.

Oppenheimer (NYSE:OPY) has a market capitalization of $433.25 million and generates $1.17 billion in revenue each year. The financial services provider earns $32.35 million in net income (profit) each year or $3.14 on an earnings per share basis.

The company employs 2,912 workers across the globe.

Oppenheimer's mailing address is 85 BROAD STREET, NEW YORK NY, 10004. The official website for the company is www.oppenheimer.com. The financial services provider can be reached via phone at (212) 668-8000, via email at info@opco.com, or via fax at 212-943-8728.